
Medtronic escapes $106.5M payment in Colibri TAVR patent suit after court overturns jury verdict
Medtronic’s CoreValve Evolut TAVR [Image from Medtronic] A court sided with Medtronic (NYSE: MDT) + , overturning a 2023 verdict ordering the medtech giant to pay a significant amount in a patent suit. Colibri Heart Valve claimed in 2019 that Medtronic …